SCI Ventures
London, Englandsciventures.com
Overview
SCI Ventures is a venture philanthropy fund dedicated to reversing paralysis by investing in scientific breakthroughs in spinal cord injury treatment. It invests in early-stage companies developing cure-oriented therapies for spinal cord injury, leveraging scientific advancements in neuron restoration, neuromodulation, and gene therapy. SCI Ventures focuses on seed and Series A financing rounds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Precision Neuroscience | Nov 2025 | VC Round | Lead |
| Tatakai | Nov 2025 | Angel | Co-investor |
| Cyllene Therapeutics | Feb 2025 | Series B | Co-investor |
| Cyllene Therapeutics | Feb 2025 | Series B | Co-investor |
| Axonis Therapeutics | Oct 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
